Skip to main content
Top
Published in: BMC Gastroenterology 1/2024

Open Access 01-12-2024 | Thrombosis | Research

Correlation between white blood cell count and intestinal resection in patients with acute mesenteric vein thrombosis

Authors: Yu Xu, Shang-Tai Dai, Hong-Qiao Lu, Wei Chen, Zhi-Wei Xiong, Jiang Liu, Yong-Jiang Tang, Shi-Kui Guo, Kun-Mei Gong

Published in: BMC Gastroenterology | Issue 1/2024

Login to get access

Abstract

Objective

Acute mesenteric vein thrombosis (AMVT) is an acute abdominal disease with onset, rapid progression, and extensive intestinal necrosis that requires immediate surgical resection. The purpose of this study was to determine the risk factors for nosocomial intestinal resection in patients with AMVT.

Methods

We retrospectively analysed 64 patients with AMVT diagnosed by CTA at the Affiliated Hospital of Kunming University of Science and Technology from January 2013 to December 2021. We compared patients who underwent intestinal resection (42 patients) with those who did not undergo intestinal resection (22 patients). The area under the ROC curve was evaluated, and a forest map was drawn.

Results

Among the 64 patients, 6 (9.38%) had a fever, 60 (93.75%) had abdominal pain, 9 (14.06%) had a history of diabetes, 8 (12.5%) had a history of deep vein thrombosis (DVT), and 25 (39.06%) had ascites suggested by B ultrasound or CT after admission. The mean age of all patients was 49.86 ± 16.25 years. The mean age of the patients in the enterectomy group was 47.71 ± 16.20 years. The mean age of the patients in the conservative treatment group (without enterectomy) was 53.95 ± 15.90 years. In the univariate analysis, there were statistically significant differences in leukocyte count (P = 0.003), neutrophil count (P = 0.001), AST (P = 0.048), total bilirubin (P = 0.047), fibrinogen (P = 0.022) and DD2 (P = 0.024) between the two groups. The multivariate logistic regression analysis showed that admission white blood cell count (OR = 1.153, 95% CI: 1.039–1.280, P = 0.007) was an independent risk factor for intestinal resection in patients with AMVT. The ROC curve showed that the white blood cell count (AUC = 0.759 95% CI: 0.620–0.897; P = 0.001; optimal threshold: 7.815; sensitivity: 0.881; specificity: 0.636) had good predictive value for emergency enterectomy for AMVT.

Conclusions

Among patients with AMVT, patients with a higher white blood cell count at admission were more likely to have intestinal necrosis and require emergency enterectomy. This study is helpful for clinicians to accurately determine whether emergency intestinal resection is needed in patients with AMVT after admission, prevent further intestinal necrosis, and improve the prognosis of patients.
Literature
1.
go back to reference Bala M, Kashuk J, Moore EE, Kluger Y, Biffl W, Gomes CA, Ben-Ishay O, Rubinstein C, Balogh ZJ, Civil I, Coccolini F, Leppaniemi A, Peitzman A, Ansaloni L, Sugrue M, Sartelli M, Di Saverio S, Fraga GP, Catena F. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2017;12:38.CrossRefPubMedPubMedCentral Bala M, Kashuk J, Moore EE, Kluger Y, Biffl W, Gomes CA, Ben-Ishay O, Rubinstein C, Balogh ZJ, Civil I, Coccolini F, Leppaniemi A, Peitzman A, Ansaloni L, Sugrue M, Sartelli M, Di Saverio S, Fraga GP, Catena F. Acute mesenteric ischemia: guidelines of the World Society of Emergency Surgery. World J Emerg Surg. 2017;12:38.CrossRefPubMedPubMedCentral
2.
go back to reference Burch J, Enofe I. Acute mesenteric ischaemia secondary to portal, splenic and superior mesenteric vein thrombosis. BMJ Case Rep. 2019;12(9). Burch J, Enofe I. Acute mesenteric ischaemia secondary to portal, splenic and superior mesenteric vein thrombosis. BMJ Case Rep. 2019;12(9).
3.
go back to reference Lauro A, Lacaille F. Short bowel syndrome in children and adults: from rehabilitation to transplantation. Expert Rev Gastroenterol Hepatol. 2019;13(1):55–70.CrossRefPubMed Lauro A, Lacaille F. Short bowel syndrome in children and adults: from rehabilitation to transplantation. Expert Rev Gastroenterol Hepatol. 2019;13(1):55–70.CrossRefPubMed
4.
go back to reference Salim S, Zarrouk M, Elf J, Gottsäter A, Ekberg O, Acosta S. Improved prognosis and low failure rate with anticoagulation as first-line therapy in mesenteric venous thrombosis. World J Surg. 2018;42(11):3803–11.CrossRefPubMedPubMedCentral Salim S, Zarrouk M, Elf J, Gottsäter A, Ekberg O, Acosta S. Improved prognosis and low failure rate with anticoagulation as first-line therapy in mesenteric venous thrombosis. World J Surg. 2018;42(11):3803–11.CrossRefPubMedPubMedCentral
5.
go back to reference Acosta S, Salim S. Management of Acute Mesenteric venous thrombosis: a systematic review of Contemporary studies. Scand J Surg. 2021;110(2):123–9.CrossRefPubMed Acosta S, Salim S. Management of Acute Mesenteric venous thrombosis: a systematic review of Contemporary studies. Scand J Surg. 2021;110(2):123–9.CrossRefPubMed
6.
go back to reference Liu D, Ye Y, Xie Q, Yin M, Yang X, Liang B, Wang S. [Predictive factors of intestinal necrosis in acute mesenteric vascular occlusive diseases]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(7):787–91.PubMed Liu D, Ye Y, Xie Q, Yin M, Yang X, Liang B, Wang S. [Predictive factors of intestinal necrosis in acute mesenteric vascular occlusive diseases]. Zhonghua Wei Chang Wai Ke Za Zhi. 2017;20(7):787–91.PubMed
7.
go back to reference Corcos O, Nuzzo A. Gastro-intestinal vascular emergencies. Best Pract Res Clin Gastroenterol. 2013;27(5):709–25.CrossRefPubMed Corcos O, Nuzzo A. Gastro-intestinal vascular emergencies. Best Pract Res Clin Gastroenterol. 2013;27(5):709–25.CrossRefPubMed
8.
go back to reference Kärkkäinen JM, Acosta S. Acute mesenteric ischemia (part I) - incidence, etiologies, and how to improve early diagnosis. Best Pract Res Clin Gastroenterol. 2017;31(1):15–25.CrossRefPubMed Kärkkäinen JM, Acosta S. Acute mesenteric ischemia (part I) - incidence, etiologies, and how to improve early diagnosis. Best Pract Res Clin Gastroenterol. 2017;31(1):15–25.CrossRefPubMed
9.
go back to reference Hoffmann M, Keck T. Mesenteriale Durchblutungsstörungen: Diagnostik Und Therapie [Management of mesenteric ischemia and mesenteric vein thrombosis]. Dtsch Med Wochenschr. 2014;139(30):1540–4.CrossRefPubMed Hoffmann M, Keck T. Mesenteriale Durchblutungsstörungen: Diagnostik Und Therapie [Management of mesenteric ischemia and mesenteric vein thrombosis]. Dtsch Med Wochenschr. 2014;139(30):1540–4.CrossRefPubMed
10.
go back to reference Wang Y, Zhao R, Xia L, Cui YP, Zhou Y, Wu XT. Predictive risk factors of intestinal necrosis in patients with mesenteric venous thrombosis: Retrospective Study from a single Center. Can J Gastroenterol Hepatol. 2019;2019:8906803.CrossRefPubMedPubMedCentral Wang Y, Zhao R, Xia L, Cui YP, Zhou Y, Wu XT. Predictive risk factors of intestinal necrosis in patients with mesenteric venous thrombosis: Retrospective Study from a single Center. Can J Gastroenterol Hepatol. 2019;2019:8906803.CrossRefPubMedPubMedCentral
11.
go back to reference Zhao H, Meng Y, Zhang P, Zhang Q, Wang F, Li Y. Predictors and risk factors for intestinal necrosis in patients with mesenteric ischemia. Ann Transl Med., Derikx JP, Schellekens DH, Acosta S. Serological markers for human intestinal ischemia: A systematic review. Best Pract Res Clin Gastroenterol. 2017;31(1):69–74. Zhao H, Meng Y, Zhang P, Zhang Q, Wang F, Li Y. Predictors and risk factors for intestinal necrosis in patients with mesenteric ischemia. Ann Transl Med., Derikx JP, Schellekens DH, Acosta S. Serological markers for human intestinal ischemia: A systematic review. Best Pract Res Clin Gastroenterol. 2017;31(1):69–74.
12.
go back to reference Paolillo C, Spallino I, Gruppo di Autoformazione Metodologica (GrAM). Can C-reactive protein and white blood cell count alone rule out an urgent condition in acute abdominal pain? Intern Emerg Med. 2016;11(1):141–2.CrossRefPubMed Paolillo C, Spallino I, Gruppo di Autoformazione Metodologica (GrAM). Can C-reactive protein and white blood cell count alone rule out an urgent condition in acute abdominal pain? Intern Emerg Med. 2016;11(1):141–2.CrossRefPubMed
13.
go back to reference Emile SH. Predictive factors for intestinal transmural necrosis in patients with Acute Mesenteric Ischemia. World J Surg. 2018;42(8):2364–72.CrossRefPubMed Emile SH. Predictive factors for intestinal transmural necrosis in patients with Acute Mesenteric Ischemia. World J Surg. 2018;42(8):2364–72.CrossRefPubMed
14.
go back to reference Wang XY, Ding WW, Liu BC, Sun SL, Fan XX, Wu XJ, Li JS. [Relative factors of transmural intestinal necrosis in acute superior mesenteric vein thrombosis]. Zhonghua Wai Ke Za Zhi. 2019;57(10):44–50.PubMed Wang XY, Ding WW, Liu BC, Sun SL, Fan XX, Wu XJ, Li JS. [Relative factors of transmural intestinal necrosis in acute superior mesenteric vein thrombosis]. Zhonghua Wai Ke Za Zhi. 2019;57(10):44–50.PubMed
15.
go back to reference Kim HK, Hwang D, Park S, Lee JM, Huh S. Treatment outcomes and risk factors for bowel infarction in patients with acute superior mesenteric venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2017;5(5):638–46.CrossRefPubMed Kim HK, Hwang D, Park S, Lee JM, Huh S. Treatment outcomes and risk factors for bowel infarction in patients with acute superior mesenteric venous thrombosis. J Vasc Surg Venous Lymphat Disord. 2017;5(5):638–46.CrossRefPubMed
16.
17.
go back to reference Elkrief L, Corcos O, Bruno O, Larroque B, Rautou PE, Zekrini K, Bretagnol F, Joly F, Francoz C, Bondjemah V, Cazals-Hatem D, Boudaoud L, De Raucourt E, Panis Y, Goria O, Hillaire S, Valla D, Plessier A. Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis. Liver Int. 2014;34(9):1314–21.CrossRefPubMed Elkrief L, Corcos O, Bruno O, Larroque B, Rautou PE, Zekrini K, Bretagnol F, Joly F, Francoz C, Bondjemah V, Cazals-Hatem D, Boudaoud L, De Raucourt E, Panis Y, Goria O, Hillaire S, Valla D, Plessier A. Type 2 diabetes mellitus as a risk factor for intestinal resection in patients with superior mesenteric vein thrombosis. Liver Int. 2014;34(9):1314–21.CrossRefPubMed
18.
go back to reference Curd LH Jr, Conrad MC. Role of sympathetics in the response to acute venous occlusion. Am J Physiol. 1977;233(2):H264–8.PubMed Curd LH Jr, Conrad MC. Role of sympathetics in the response to acute venous occlusion. Am J Physiol. 1977;233(2):H264–8.PubMed
19.
go back to reference Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology. 2003;125(5):1452–61.CrossRefPubMed Tsai MH, Iwakiri Y, Cadelina G, Sessa WC, Groszmann RJ. Mesenteric vasoconstriction triggers nitric oxide overproduction in the superior mesenteric artery of portal hypertensive rats. Gastroenterology. 2003;125(5):1452–61.CrossRefPubMed
20.
go back to reference Mahmoud MF, Nabil M, Abdo W, Abdelfattah MAO, El-Shazly AM, El Kharrassi Y, Sobeh M. Syzygium samarangense leaf extract mitigates indomethacin-induced gastropathy via the NF-κB signaling pathway in rats. Biomed Pharmacother. 2021 Jul;139:111675. Mahmoud MF, Nabil M, Abdo W, Abdelfattah MAO, El-Shazly AM, El Kharrassi Y, Sobeh M. Syzygium samarangense leaf extract mitigates indomethacin-induced gastropathy via the NF-κB signaling pathway in rats. Biomed Pharmacother. 2021 Jul;139:111675.
Metadata
Title
Correlation between white blood cell count and intestinal resection in patients with acute mesenteric vein thrombosis
Authors
Yu Xu
Shang-Tai Dai
Hong-Qiao Lu
Wei Chen
Zhi-Wei Xiong
Jiang Liu
Yong-Jiang Tang
Shi-Kui Guo
Kun-Mei Gong
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2024
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/s12876-024-03172-4

Other articles of this Issue 1/2024

BMC Gastroenterology 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine